Standard
Harvard
Pottie, E, Kupriyanova, OV, Brandt, AL, Laprairie, RB
, Shevyrin, VA & Stove, CP 2021, '
Serotonin 2A Receptor (5-HT2AR) Activation by 25H-NBOMe Positional Isomers: In Vitro Functional Evaluation and Molecular Docking',
ACS Pharmacology and Translational Science, Том. 4, № 2, стр. 479-487.
https://doi.org/10.1021/acsptsci.0c00189APA
Pottie, E., Kupriyanova, O. V., Brandt, A. L., Laprairie, R. B.
, Shevyrin, V. A., & Stove, C. P. (2021).
Serotonin 2A Receptor (5-HT2AR) Activation by 25H-NBOMe Positional Isomers: In Vitro Functional Evaluation and Molecular Docking.
ACS Pharmacology and Translational Science,
4(2), 479-487.
https://doi.org/10.1021/acsptsci.0c00189Vancouver
Author
BibTeX
@article{4650c5d6635444e7a26baffa3269bf6e,
title = "Serotonin 2A Receptor (5-HT2AR) Activation by 25H-NBOMe Positional Isomers: In Vitro Functional Evaluation and Molecular Docking",
keywords = "bioassay, molecular docking, new psychoactive substances, psychedelic, serotonin receptor, structure-activity relationship",
author = "Eline Pottie and Kupriyanova, {Olga V.} and Brandt, {Asher L.} and Laprairie, {Robert B.} and Shevyrin, {Vadim A.} and Stove, {Christophe P.}",
note = "Funding Information: C.P.S. acknowledges funding by the Research Foundation-Flanders (FWO) [G069419N and G0B8817N] and the Ghent University Special Research Fund (BOF) [01J15517]. O.V.K. acknowledges support by the subsidy allocated to Kazan Federal University for the state assignment in the sphere of scientific activities (Project 0671-2020-0058). A.L.B. and R.B.L. acknowledge support by a partnership grant from GlaxoSmithKline and the Canadian Institutes of Health Research (CIHR) [RN323670-386247]. V.A.S. acknowledges the Russian Science Foundation for financially supporting this work, Project 20-13-00089. The authors specifically acknowledge the reviewers for their helpful assessment of the manuscript. Publisher Copyright: {\textcopyright} 2021 American Chemical Society. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = apr,
day = "9",
doi = "10.1021/acsptsci.0c00189",
language = "English",
volume = "4",
pages = "479--487",
journal = "ACS Pharmacology and Translational Science",
issn = "2575-9108",
publisher = "American Chemical Society",
number = "2",
}
RIS
TY - JOUR
T1 - Serotonin 2A Receptor (5-HT2AR) Activation by 25H-NBOMe Positional Isomers: In Vitro Functional Evaluation and Molecular Docking
AU - Pottie, Eline
AU - Kupriyanova, Olga V.
AU - Brandt, Asher L.
AU - Laprairie, Robert B.
AU - Shevyrin, Vadim A.
AU - Stove, Christophe P.
N1 - Funding Information: C.P.S. acknowledges funding by the Research Foundation-Flanders (FWO) [G069419N and G0B8817N] and the Ghent University Special Research Fund (BOF) [01J15517]. O.V.K. acknowledges support by the subsidy allocated to Kazan Federal University for the state assignment in the sphere of scientific activities (Project 0671-2020-0058). A.L.B. and R.B.L. acknowledge support by a partnership grant from GlaxoSmithKline and the Canadian Institutes of Health Research (CIHR) [RN323670-386247]. V.A.S. acknowledges the Russian Science Foundation for financially supporting this work, Project 20-13-00089. The authors specifically acknowledge the reviewers for their helpful assessment of the manuscript.
Publisher Copyright: © 2021 American Chemical Society.
Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/4/9
Y1 - 2021/4/9
KW - bioassay
KW - molecular docking
KW - new psychoactive substances
KW - psychedelic
KW - serotonin receptor
KW - structure-activity relationship
UR - http://www.scopus.com/inward/record.url?scp=85103455365&partnerID=8YFLogxK
UR - https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=tsmetrics&SrcApp=tsm_test&DestApp=WOS_CPL&DestLinkType=FullRecord&KeyUT=000639067200009
UR - https://elibrary.ru/item.asp?id=46762668
U2 - 10.1021/acsptsci.0c00189
DO - 10.1021/acsptsci.0c00189
M3 - Article
AN - SCOPUS:85103455365
VL - 4
SP - 479
EP - 487
JO - ACS Pharmacology and Translational Science
JF - ACS Pharmacology and Translational Science
SN - 2575-9108
IS - 2
ER -
